Incyte stops mid-stage study of colorectal cancer treatment

(Reuters) - Incyte Corp said on Wednesday that it would stop a mid-stage study on its combination cancer treatment after it failed to show sufficient levels of efficacy in an interim analysis.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro